The Pharma Partnering Summit 2026 announces its highly anticipated return as the premier global forum dedicated exclusively to Business Development ...
An enterprise AI platform bringing decision-grade intelligence to regulated pharmaceutical operations This partnership ...
This article is authored by Tushar Gupta, COO, Jubilant Biosys Limited (CRDMO).
Aurobindo's wholly owned subsidiary, Aurobindo Pharma USA, has entered into a collaboration and license agreement with an unnamed global pharma company for the development and commercialization of ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
THE Philippine Economic Zone Authority (Peza) and Unilab Foundation Inc. (ULF) have signed an agreement aimed at ...
“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...
U.S. pharmaceutical company Eli Lilly plans to disclose the topline results of its phase 3 clinical trial for “remternutux,” a new drug candidate developed as a successor to its Alzheimer’s treatment ...
Opinion: Freedom-to-operate analysis must be understood as a continuous, integrated process that evolves alongside science, regulation, and commercial strategy.
Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...
Ascentage Pharma will be conducting a multicenter, open-label Phase I study designed to evaluate the safety, tolerability, pharmacokinetic (PK) profile, and preliminary efficacy of APG-3288 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results